QUOTE AND NEWS
GenEng News  Feb 20  Comment 
AbbVie will partner with Voyager Therapeutics to develop and commercialize gene therapies for Alzheimer's disease and other neurodegenerative diseases, through a collaboration that could generate more than $1.1 billion-plus for Voyager, the...
GenEng News  Jan 31  Comment 
Pulmonary fibrosis is a fatal lung condition that can be associated with lung cells exhibiting short telomeres, the protective structures at the ends of chromosomes. Researchers in Spain now report on the use of an adeno-associated virus (AAV)...
MarketWatch  Jan 30  Comment 
Shares of gene therapy companies fell sharply Tuesday, after a report by a prominent scientist revealed the safety concerns that led him to resign recently from Solid Bioscience Inc.'s scientific advisory board. Gene therapy researcher James...
GenEng News  Dec 19  Comment 
FDA approved Spark Therapeutics’ gene therapy Luxturna (voretigene neparvovec-rzyl) for treating children and adults with the rare, inherited blindness disorder biallelic RPE65 mutation-associated retinal dystrophy. Approval of the one-time...
GenEng News  Nov 13  Comment 
Novartis will use Homology Medicines’ proprietary adeno-associated virus (AAV) gene-editing platform technology to develop new treatments for select ophthalmic targets and a hemoglobinopathy disease, the companies said today. Under a...
GenEng News  Oct 31  Comment 
Voyager Therapeutics said it will develop its lead candidate VY-AADC01  gene therapy for advanced Parkinson’s disease on its own, retaining full global rights, after Genzyme, a Sanofi company, opted against exercising its exclusive development...
GenEng News  Sep 19  Comment 
Scientists in North and South America have developed a form of gene therapy that could feasibly help to treat alcoholism by causing unpleasant physical side effects in individuals who imbibe. The approach harnesses a short hairpin RNA (shRNA),...





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki